CD8A and neoplasm: An example of this, the immunoscore, developed by Galon et al. and based on the quantification of CD3 and CD8-positive T cells using digital imaging analysis, was found to outperform the Tumor-Node-Metastases (TNM) classification for disease-free survival and overall survival and could help predict response to therapy [9–11].